摘要
糖尿病肾病是糖尿病最主要的微血管并发症,也是引起终末期肾病的主要原因,治疗棘手。安海燕教授认为该病总属“本虚标实”之证,并强调“肾络瘀阻”为该病核心病机,贯穿始终。重视分期论治,标本兼顾,虚实并举,遣方用药时,灵活伍用“辛通”“柔润”类中药,将“辛润通络法”巧用于各期的治疗中,并随证化裁,临证每获效验。本文总结并探讨安海燕教授治疗糖尿病肾病的经验,并附医案一则予以佐证,以期为临床治疗该病拓宽思路。
Diabetic nephropathy is the major microvascular complication of diabetes,and it is also the main cause of end-stage renal disease,the treatment is difficult.Professor An Haiyan believes that the disease always belongs to the syndrome of“deficiency of root cause and excess of manifestation”,and emphasizes that“blood stasis of kidney collaterals”is the core pathogenesis of the disease,which runs through the whole process.Pay attention to treatment by stages,give consideration to both manifestation and root cause,and develop both deficiency and excess.When the prescription is used,it should be flexibly combined with“xintong”and“rourun”Chinese medicine,and“xinrun tongluo method”should be skillfully used in the treatment of each stage,which should be determined according to the syndrome.Each clinical certificate is validated.This article summarizes and discusses Professor An Haiyan’s experience in treating diabetic nephropathy,and attaches a case of medical treatment to prove it,so as to broaden the train of thought for clinical treatment of this disease.
作者
赵静
安海燕
曹云松
郭晓媛
ZHAO Jing;AN Haiyan;CAO Yunsong;GUO Xiaoyuan(The Second Clinical School,Beijing University of Chinese Medicine,Beijing 100029,China;Department of Nephrology,Dongfang Hospital,Beijing University of Chinese Medicine,Beijing 100078,China)
出处
《中国医药导报》
CAS
2022年第20期140-143,147,共5页
China Medical Herald
基金
国家自然科学基金资助项目(81904144)。
关键词
糖尿病肾病
辛润通络法
肾络瘀阻
安海燕
临证经验
Diabetic nephropathy
Xinrun tongluo method
Blood stasis of kidney collaterals
An Haiyan
Clinical experience
作者简介
赵静(1994.3-),女,北京中医药大学2019级中西医结合肾病专业在读硕士研究生,研究方向:中医药防治肾脏病;通讯作者:安海燕(1966.1-),女,主任医师,教授,硕士生导师,研究方向:中医药防治肾脏病。
